Vaccine value profile for severe fever with thrombocytopenia syndrome (SFTS).

Saved in:
Bibliographic Details
Title: Vaccine value profile for severe fever with thrombocytopenia syndrome (SFTS).
Authors: Skrip L; Faculty of Epidemiology and Public Health, London School of Hygiene and Tropical Medicine, London, United Kingdom; Department of Infectious Disease Epidemiology and Dynamics, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan. Electronic address: laura.skrip@nagasaki-u.ac.jp., Hidano A; Department of Infectious Disease Epidemiology and Dynamics, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan; Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, United Kingdom., Poovorawan Y; Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand., Khongwichit S; Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand., Kato H; Japan Institute for Health Security (JIHS), Tokyo, Japan., Kapell S; Department of Vaccine Informatics, Institute of Tropical Medicine (NEKKEN), Nagasaki University, Nagasaki, Japan; NEC OncoImmunity, Oslo, Norway., Abe M; KM Biologics Co., Ltd., Japan; Dejima Infectious Disease Research Alliance, Nagasaki University, Japan., Jung SM; Department of Infectious Disease Epidemiology and Dynamics, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan; Carolina Population Center, University of North Carolina at Chapel Hill, North Carolina, USA; Saw Swee Hock School of Public Health, National University of Singapore, Singapore., Jit M; Department of Global and Environmental Health, School of Global Public Health, New York University, New York, United States of America., Kim KH; Department of Internal Medicine, Pusan National University School of Medicine, Republic of Korea., Yi J; Department of Laboratory Medicine, Pusan National University School of Medicine, Republic of Korea., Miyazaki T; Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan; Clinical Research Support Center, University of Miyazaki Hospital, Miyazaki, Japan., Kawaguchi T; Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan., Okabayashi T; Center for Animal Disease Control (CADIC), University of Miyazaki, Miyazaki, Japan., Chae JS; Laboratory of Veterinary Internal Medicine, BK21 FOUR Future Veterinary Medicine Leading Education and Research Centre, Research Institute for Veterinary Science and College of Veterinary Medicine, Seoul National University, Seoul, Republic of Korea., Ariyoshi K; Department of Infectious Disease Epidemiology and Dynamics, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan., Edmunds WJ; Faculty of Epidemiology and Public Health, London School of Hygiene and Tropical Medicine, London, United Kingdom; Department of Infectious Disease Epidemiology and Dynamics, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan., Morita K; Dejima Infectious Disease Research Alliance, Nagasaki University, Japan.
Source: Vaccine [Vaccine] 2026 May 22; Vol. 82, pp. 128596. Date of Electronic Publication: 2026 Apr 20.
Publication Type: Journal Article; Review
Journal Info: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1873-2518
DOI:10.1016/j.vaccine.2026.128596